MoneyWorks4Me

Hester Biosciences gets nod to raise up to Rs 150 crore

18 Dec 2019 Evaluate

Hester Biosciences has received an approval for issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 150 crore. The Board of Directors in their meeting held on December 18, 2019, approved the same.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..